This brand name is authorized in Nigeria.
The drug SOLIFEN contains one active pharmaceutical ingredient (API):
1
|
UNII
KKA5DLD701 - SOLIFENACIN SUCCINATE
|
|
Solifenacin is a competitive, specific cholinergic-receptor antagonist. In vitro and in vivo pharmacological studies indicate that solifenacin is a competitive inhibitor of the muscarinic M3 subtype receptor. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-9699 | Tablet | SOLIFEN TABLET 5MG TAB 5 mg 3x10 | 105 RNW-PP-355342 SOLIFEN TABLET 5MG SOLIFENACIN SUCCINATE 5MG SOLIFENACIN SUCCINATE 5MG; LACTOSE (PHARMATOSE DCL 11) – 75.42MG; MICROCRYSTALLINE CELLULOSE (AVICEL PH 102) – 37.705MG; DESSICATE CORN STARCH PASTE – 6.25MG; MAGNESIUM STEARATE – 0.625MG; OPADRY WHITE YS-1-7027 – 3.75MG; PURIFIED TALC – Q.S; PURIFIED WATER – 18.75MG B4-9699 Drugs Imported Products 310 POM 1 9/26/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan | 21/12/2023 |
| B4-9700 | Tablet | SOLIFEN 10MG TABLET TAB 10 mg 3x10 | 129 RNW-PP-355356 SOLIFEN 10MG TABLET SOLIFENACIN SUCCINATE 10MG SOLIFENACIN SUCCINATE 10MG; LACTOSE (PHARMATOSE DCL 11) – 75.42MG; MICROCRYSTALLINE CELLULOSE (AVICEL PH 102) – 37.705MG; DESSICATE CORN STARCH PASTE – 6.25MG; MAGNESIUM STEARATE – 0.625MG; OPADRY WHITE YS-1-7027 – 3.75MG; PURIFIED TALC – Q.S; PURIFIED WATER – 18.75MG B4-9700 Drugs Imported Products 310 POM 1 9/26/2023 GETZ PHARMA NIGERIA LIMITED, PLOT 2, IJAODOLA CLOSE, OFF ADEYEMO ALAKIJA STREET, IKEJA GRA, LAGOS. 8165370750 nneka.obegolu@getzpharma.com GETZ PHARMA (PRIVATE) LIMITED, 29 – 30/27, KORANGI INDUSTRIAL AREA,KARACHI-74900 PAKISTAN , Pakistan | 21/12/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G04BD08 | Solifenacin | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BD Urinary antispasmodics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-9699, B4-9700 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.